ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 253 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q4 2020. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,230,000 | -17.2% | 152,014 | +42.0% | 0.01% | 0.0% |
| Q1 2022 | $1,485,000 | -50.4% | 107,041 | +0.3% | 0.01% | -50.0% |
| Q4 2021 | $2,996,000 | -56.7% | 106,774 | -47.6% | 0.03% | -15.2% |
| Q3 2021 | $6,920,000 | +70.9% | 203,608 | +105.5% | 0.03% | -15.4% |
| Q2 2021 | $4,048,000 | +8.0% | 99,096 | +6.4% | 0.04% | +5.4% |
| Q1 2021 | $3,748,000 | -33.1% | 93,094 | -1.7% | 0.04% | -40.3% |
| Q4 2020 | $5,599,000 | +19.4% | 94,680 | -1.8% | 0.06% | -3.1% |
| Q3 2020 | $4,690,000 | +267.0% | 96,462 | +265.0% | 0.06% | +204.8% |
| Q2 2020 | $1,278,000 | +229.4% | 26,425 | +89.4% | 0.02% | +162.5% |
| Q1 2020 | $388,000 | – | 13,950 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 3,030,434 | $23,152,516 | 15.55% |
| BERYLSON CAPITAL PARTNERS, LLC | 289,726 | $2,213,507 | 6.45% |
| Matrix Capital Management Company, LP | 11,572,590 | $88,414,588 | 1.69% |
| Pier Capital, LLC | 1,012,401 | $7,734,744 | 1.27% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $229,151,929 | 1.15% |
| Eagle Health Investments LP | 607,860 | $4,644,050 | 1.07% |
| Triatomic Management LP | 130,805 | $999,350 | 0.84% |
| Aristotle Atlantic Partners, LLC | 1,880,567 | $14,367,532 | 0.80% |
| Senator Investment Group LP | 1,000,000 | $7,640,000 | 0.69% |
| ARK Investment Management | 9,201,245 | $70,297,512 | 0.61% |